IDEXX LABORATORIES INC /DE — Director's Dealing 2022

Feb 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2022-02-18

Reporting Person: AYERS JONATHAN W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-18	Common Stock	M	706	$141.60	Acquired	630196	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-18	Incentive Stock Option (right-to-buy)	$141.60	M	706	Disposed	2027-02-13	Common Stock (706)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Indirect

Footnotes

F1: Grant of option to buy 706 shares of IDEXX Laboratories, Inc. common stock that became exercisable in one installment on February 14, 2022.

F2: Not applicable.